common overemphasis on P values (as in the letter), 2 which are liable to major false-negative risks with small samples, we emphasized descriptive statistics of effect sizes (number of episodes per year). Second, since we predicted and found that only 25% of the sample would have rapid cycling, we planned a priori, 7 years before the data analysis, to compare the rapid-cycling sample (n = 17) to the much larger non-rapid cycling sample (n = 53). The rationale was that, in such an analysis, large descriptive differences, as described above, would be statistically significant when P values were applied (as detailed in the article; namely, an about 3-fold increased rate of depressive episodes in rapid-cycling vs non-rapid cycling subjects continued on antidepressants; mean of 1.29 vs 0.42 depressive episodes per year, P = .04).
If these data "make no sense, " a solution may be found in study of the standard text in the field, 3 prospective outcome studies, 4 and comprehensive review articles, 5 which clearly describe how in bipolar disorder-including rapid-cycling-depressive episodes are more frequent and lengthy than manic episodes. Our data are consistent with this literature; we observed about 2-fold more depressive versus manic episodes in our rapid-cycling subjects (over 3 years, 12 manic episodes in 6 subjects vs 20 depressive episodes in 13 subjects). Our study confirms the importance of the concept of "cycling" or "recurrence" (not just polarity) as a key aspect of manicdepressive illness-a notion that dates back to Kraepelin. 3 In an illness in which most cycles involve depression more frequently and severely than mania, antidepressants appear to induce not just acute mania, but long-term cycle acceleration with worsening depressive morbidity-a concept about which some of us have published repeatedly for decades. 3, 6 "The great tragedy of science-," Thomas Huxley called it, "the slaying of a beautiful hypothesis by an ugly fact. " Lamentably, the antidepressant faith does not fare well in randomized studies of bipolar disorder (or even, to some extent, in major depressive disorder 7 ). Our data are not definitive, but they are based on the most valid research design we have, and they are consistent with the only other available randomized data on antidepressants in rapid-cycling bipolar disorder. 3, 6 Facts are stubborn, sometimes even tragic, things.
